Item:Q15317: Difference between revisions

Revision as of 18:23, 4 December 2023 Fire (talk \| contribs) Bureaucrats, Interface administrators, Administrators 132,236 edits ‎Added [en] aliases: [(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[hydroxy-[hydroxy-[3-hydroxy-2,2-dimethyl-3-[2-(2-sulfanylethylcarbamoyl)ethylcarbamoyl]propoxy]phosphoryl]oxy-phosphoryl]oxymethyl]oxolan-3-yl]oxyphosphonic acid, [(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[hydroxy-[hydroxy-[3-hydroxy-2,2-dimethyl-3-[2-(2-sulfanylethylcarbamoyl)ethylcarbamoyl]propoxy]phosphoryl]oxy-phosphoryl]oxymethyl]tetrahydrofuran-3-yl]oxyphosphonic acid, [(2S,3S,4R,5R)-5-(6-aminopurin-9... ← Older edit	Revision as of 18:23, 4 December 2023 Fire (talk \| contribs) Bureaucrats, Interface administrators, Administrators 132,236 edits ‎Created claim: instance of (P2): group of stereoisomers (Q10008) Newer edit →
	Property / instance of
		group of stereoisomers
	Property / instance of: group of stereoisomers / rank
		Normal rank